“Comparative Efficacy and Safety of Individual SGLT2 Inhibitors (Dapagliflozin, Empagliflozin, and Canagliflozin) on Kidney Function Decline in CKD: A Systematic Review and Network Meta-Analysis”. Open Access Indonesian Journal of Medical Reviews, vol. 5, no. 6, Nov. 2025, pp. 1772-89, https://doi.org/10.37275/oaijmr.v5i6.818.